Despite promising preclinical results, no natural compound has yet received FDA approval for AD treatment, largely due to limitations in clinical study designs, inconsistent dosing regimens, and the absence of standardized protocols (Mohamed Yusof and Mohd Fauzi 2024)
It comprises a complex ecosystem of proteins, receptors, and signalling pathways
this, in turn, resulted in the upregulated expression of telomere repeat-binding factor 1/2 (TRF1/TRF2) proteins and strict dependence on p53/p21 signaling, followed by irreversible G2/M cell cycle arrest, ultimately leading to apoptosis
Not directly
doi: 10.1016/j.jare.2018.05.010 24 KazmierskaK
More frequent blood glucose tracking, possibly including continuous glucose tracking systems, provides detailed glucose data